文献速递重症综合管理与镇静镇痛

脓毒性休克极早期物理治疗对骨骼肌的影响:一项随机对照试验

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论脓毒性休克72小时内启动每日两次手法 mobilization 加30分钟被动/主动 cycling 治疗可保留肌纤维横截面积,且耐受良好。

该随机对照试验在三级混合ICU纳入21例脓毒性休克72小时内成人患者,随机分为对照组(每日一次手法 mobilization)和干预组(每日两次手法 mobilization 加30分钟被动/主动 cycling)。第1天和第7天行骨骼肌活检和电生理检查。第7天干预组肌萎缩F-box蛋白mRNA和肌肉环指蛋白-1 mRNA仅在其组内下降,但组间无差异;肌纤维横截面积对照组下降25.8%±21.6%,干预组增加12.4%±22.5%(p=0.005)。干预组自噬过度激活较低但未被抑制,合成代谢和炎症标志物未改变,干预耐受良好。结论认为脓毒性休克第一周早期物理治疗安全并能保留肌纤维横截面积。

要点

  • 脓毒性休克72小时内开始每日两次手法 mobilization 加30分钟被动/主动 cycling 治疗,患者耐受良好。
  • 第7天肌纤维横截面积对照组下降25.8%±21.6%,干预组增加12.4%±22.5%,组间差异p=0.005。
  • 肌萎缩F-box蛋白mRNA第7天对照组变化-7.3%±138.4%,干预组-56.4%±37.4%,组间p=0.23无差异。
  • 肌肉环指蛋白-1 mRNA第7天对照组变化-30.8%±66.9%,干预组-62.7%±45.5%,组间p=0.15无差异。
  • 合成代谢和炎症标志物未因干预而改变,分子调控提示干预组自噬过度激活较低但未被抑制。

适用人群与场景

  • 因脓毒性休克入住三级混合ICU的成人患者,且在发病72小时内纳入。

处置流程与药物剂量

  • 对照组:每日一次手法 mobilization。
  • 干预组:每日两次 sessions,每次包括手法 mobilization 和30分钟被动/主动 cycling 治疗。

研究设计与关键结果

  • 研究类型:随机对照试验;样本量21例,最终分析对照组10例、干预组8例,3例在第二次肌肉活检前死亡。
  • 主要终点:第7天肌纤维横截面积(µm)对照组变化-25.8%±21.6%,干预组变化12.4%±22.5%,p=0.005。
  • 关键次要终点:肌萎缩F-box蛋白mRNA第7天对照组变化-7.3%±138.4%,干预组-56.4%±37.4%,p=0.23;肌肉环指蛋白-1 mRNA对照组变化-30.8%±66.9%,干预组-62.7%±45.5%,p=0.15。
  • 分子调控提示干预组自噬过度激活较低但未被抑制;合成代谢和炎症标志物未因干预而改变;干预耐受良好。

证据类型、等级与局限

  • 证据类型:随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于脓毒性休克72小时内成人患者,每日两次手法 mobilization 加30分钟被动/主动 cycling 治疗可保留肌纤维横截面积,且耐受良好。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: As the catabolic state induced by septic shock together with the physical inactivity of patients lead to the rapid loss of muscle mass and impaired function, the purpose of this study was to test whether an early physical therapy during the onset of septic shock regulates catabolic signals and preserves skeletal muscle mass.

DESIGN: Randomized controlled trial.

SETTING: Tertiary mixed ICU.

PATIENTS: Adult patients admitted for septic shock within the first 72 hours.

INTERVENTIONS: Patients were assigned randomly into two groups. The control group benefited from manual mobilization once a day. The intervention group had twice daily sessions of both manual mobilization and 30-minute passive/active cycling therapy.

MEASUREMENTS AND MAIN RESULTS: Skeletal muscle biopsies and electrophysiology testing were performed at day 1 and day 7. Muscle biopsies were analyzed for histology and molecular components of signaling pathways regulating protein synthesis and degradation as well as inflammation markers. Hemodynamic values and patient perception were collected during each session. Twenty-one patients were included. Three died before the second muscle biopsy. Ten patients in the control and eight in the intervention group were analyzed. Markers of the catabolic ubiquitin-proteasome pathway, muscle atrophy F-box and muscle ring finger-1 messenger RNA, were reduced at day 7 only in the intervention group, but without difference between groups (muscle atrophy F-box: -7.3% ± 138.4% in control vs -56.4% ± 37.4% in intervention group; p = 0.23 and muscle ring finger-1: -30.8% ± 66.9% in control vs -62.7% ± 45.5% in intervention group; p = 0.15). Muscle fiber cross-sectional area (µm) was preserved by exercise (-25.8% ± 21.6% in control vs 12.4% ± 22.5% in intervention group; p = 0.005). Molecular regulations suggest that the excessive activation of autophagy due to septic shock was lower in the intervention group, without being suppressed. Markers of anabolism and inflammation were not modified by the intervention, which was well tolerated by the patients.

CONCLUSIONS: Early physical therapy during the first week of septic shock is safe and preserves muscle fiber cross-sectional area.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hickmann CE, Castanares-Zapatero D, Deldicque L, et al. Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial. Crit Care Med. 2018. PMID: 29957714. doi:10.1097/CCM.0000000000003263

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。